Jan 14, 2025 from 3:00 PM to 3:40 PM PST 43rd Annual J.P. Morgan Healthcare Conference Link to webcast Genmab_JP Morgan 2025_Final_Public.pdf 1.1 MB Jan 28, 2025 Deadline for shareholders to submit any items for consideration for the agenda of the Annual General Meeting in writing to the Board of Directors Feb 12, 2025 Publication of the Annual Report for 2024 (after 5:00 PM CET) Mar 12, 2025 Annual General Meeting 2025 May 8, 2025 Publication of the Interim Report for the First Quarter 2025 (after 5:00 PM CEST) Aug 7, 2025 Publication of the Interim Report for the First Half 2025 (after 5:00 PM CEST) Nov 6, 2025 Publication of the Interim Report for the First Nine Months 2025 (after 5:00 PM CET) Dec 31, 2025 Financial Calendar Year End Dec 31, 2024 Financial Calendar Year End Dec 11, 2024 5:00 PM CET 2024 R&D Update and ASH Data Review Genmab hosted its 2024 R&D Update and ASH Data Review virtually on Wednesday, December 11, 2024.This meeting was not an official program of the ASH Annual Meeting. Listen to the webcast replay Supporting Materials Genmab R&D Update and ASH Data Review - December 2024 3.3 MB Dec 3, 2024 8:30 PM CET Citi’s 2024 Global Healthcare Conference Fireside Chat with Chief Financial Officer Anthony Pagano. Listen to Webcast Nov 19, 2024 4:30 PM CET Jefferies Healthcare Conference Fireside Chat with Chief Executive Officer, Jan van de Winkel, and Chief Financial Officer, Anthony Pagano. Listen to Webcast Nov 6, 2024 Publication of the Interim Report for the First Nine Months 2024 (after 5:00 PM CET) On November 6, Genmab announced its financial results for the first nine months of 2024. Replay the Webcast Supporting Materials Interim Report for the First Nine Months of 2024 1.5 MB Genmab First Nine Months 2024 Financial Results Presentation 4.1 MB Sep 4, 2024 1:05 PM EDT Morgan Stanley 22nd Annual Global Healthcare Conference Fireside Chat with Chief Executive Officer Jan van de Winkel and Chief Financial Officer Anthony Pagano. Listen to Webcast Aug 8, 2024 Publication of the Interim Report for the First Half 2024 (after 5:00 PM CEST) On August 8, Genmab announced its financial results for the first six months of 2024. Replay the webcast Supporting Materials Interim Report for the First Half of 2024 1.3 MB Genmab First Half 2024 Financial Results Presentation 4.6 MB Jun 10, 2024 9:20 AM EDT Goldman Sachs 45th Annual Global Healthcare Conference Fireside Chat with Chief Financial Officer, Anthony Pagano, and Chief Operating Officer, Anthony Mancini. Listen to the Webcast Jun 3, 2024 9:00 AM CDT Virtual mid- to late-stage pipeline update at ASCO 2024 On Monday, June 3 Genmab held a review of data presented at ASCO from its mid- to late-stage pipeline. This meeting was not an official program of the ASCO Annual Meeting. Listen to the Webcast Replay Supporting Materials Genmab's Virtual mid- to late-stage pipeline update at ASCO 2024 963.7 KB May 2, 2024 Publication of the Interim Report for the First Quarter 2024 (after 5:00 PM CEST) Supporting Materials Genmab Q1 2024 Financial Results Presentation 4.1 MB Interim Report for the First Quarter of 2024 1.3 MB Mar 13, 2024 Annual General Meeting 2024 Feb 14, 2024 Publication of the Annual Report for 2023 (after 5:00 PM CET) Supporting Materials Genmab 2023 Full Year Financial Results Presentation 5 MB Jan 30, 2024 Deadline for shareholders to submit any items for consideration for the agenda of the Annual General Meeting in writing to the Board of Directors Jan 10, 2024 from 11:15 AM to 11:55 AM PST 42nd Annual J.P. Morgan Healthcare Conference Link to webcast Supporting Materials Genmab 2024 JPM Presentation_vFinal_Public.pdf 7.2 MB
Jan 14, 2025 from 3:00 PM to 3:40 PM PST 43rd Annual J.P. Morgan Healthcare Conference Link to webcast Genmab_JP Morgan 2025_Final_Public.pdf 1.1 MB
Jan 28, 2025 Deadline for shareholders to submit any items for consideration for the agenda of the Annual General Meeting in writing to the Board of Directors
Dec 11, 2024 5:00 PM CET 2024 R&D Update and ASH Data Review Genmab hosted its 2024 R&D Update and ASH Data Review virtually on Wednesday, December 11, 2024.This meeting was not an official program of the ASH Annual Meeting. Listen to the webcast replay Supporting Materials Genmab R&D Update and ASH Data Review - December 2024 3.3 MB
Dec 3, 2024 8:30 PM CET Citi’s 2024 Global Healthcare Conference Fireside Chat with Chief Financial Officer Anthony Pagano. Listen to Webcast
Nov 19, 2024 4:30 PM CET Jefferies Healthcare Conference Fireside Chat with Chief Executive Officer, Jan van de Winkel, and Chief Financial Officer, Anthony Pagano. Listen to Webcast
Nov 6, 2024 Publication of the Interim Report for the First Nine Months 2024 (after 5:00 PM CET) On November 6, Genmab announced its financial results for the first nine months of 2024. Replay the Webcast Supporting Materials Interim Report for the First Nine Months of 2024 1.5 MB Genmab First Nine Months 2024 Financial Results Presentation 4.1 MB
Sep 4, 2024 1:05 PM EDT Morgan Stanley 22nd Annual Global Healthcare Conference Fireside Chat with Chief Executive Officer Jan van de Winkel and Chief Financial Officer Anthony Pagano. Listen to Webcast
Aug 8, 2024 Publication of the Interim Report for the First Half 2024 (after 5:00 PM CEST) On August 8, Genmab announced its financial results for the first six months of 2024. Replay the webcast Supporting Materials Interim Report for the First Half of 2024 1.3 MB Genmab First Half 2024 Financial Results Presentation 4.6 MB
Jun 10, 2024 9:20 AM EDT Goldman Sachs 45th Annual Global Healthcare Conference Fireside Chat with Chief Financial Officer, Anthony Pagano, and Chief Operating Officer, Anthony Mancini. Listen to the Webcast
Jun 3, 2024 9:00 AM CDT Virtual mid- to late-stage pipeline update at ASCO 2024 On Monday, June 3 Genmab held a review of data presented at ASCO from its mid- to late-stage pipeline. This meeting was not an official program of the ASCO Annual Meeting. Listen to the Webcast Replay Supporting Materials Genmab's Virtual mid- to late-stage pipeline update at ASCO 2024 963.7 KB
May 2, 2024 Publication of the Interim Report for the First Quarter 2024 (after 5:00 PM CEST) Supporting Materials Genmab Q1 2024 Financial Results Presentation 4.1 MB Interim Report for the First Quarter of 2024 1.3 MB
Feb 14, 2024 Publication of the Annual Report for 2023 (after 5:00 PM CET) Supporting Materials Genmab 2023 Full Year Financial Results Presentation 5 MB
Jan 30, 2024 Deadline for shareholders to submit any items for consideration for the agenda of the Annual General Meeting in writing to the Board of Directors
Jan 10, 2024 from 11:15 AM to 11:55 AM PST 42nd Annual J.P. Morgan Healthcare Conference Link to webcast Supporting Materials Genmab 2024 JPM Presentation_vFinal_Public.pdf 7.2 MB